Current Management of Fungal Infections
- 1 January 2001
- journal article
- review article
- Published by Springer Nature in Drugs
- Vol. 61 (Supplement) , 13-25
- https://doi.org/10.2165/00003495-200161001-00002
Abstract
The management of superficial fungal infections differs significantly from the management of systemic fungal infections. Most superficial infections are treated with topical antifungal agents, the...Keywords
This publication has 121 references indexed in Scilit:
- Itraconazole for the treatment of tinea pedis: A dosage of 400 mg/day given for 1 week is similar in efficacy to 100 or 200 mg/day given for 2 to 4 weeksJournal of the American Academy of Dermatology, 1997
- Treatment and Prophylaxis of Tinea InfectionsDrugs, 1996
- A double-blind, randomized, placebo-controlled evaluation of short-term treatment with oral itraconazole in patients with tinea versicolorJournal of the American Academy of Dermatology, 1996
- Treatment of dermatophyte nail infections: An open randomized study comparing intermittent terbinafine therapy with continuous terbinafine treatment and intermittent itraconazole therapyJournal of the American Academy of Dermatology, 1996
- International summit on cutaneous antifungal therapy: Boston, Massachusetts, Nov. 11–13, 1994Journal of the American Academy of Dermatology, 1995
- Pharmacokinetic Optimisation of Oral Antifungal TherapyClinical Pharmacokinetics, 1993
- Posttreatment itraconazole levels in the nailJournal of the American Academy of Dermatology, 1992
- A Controlled Trial of Fluconazole to Prevent Fungal Infections in Patients Undergoing Bone Marrow TransplantationNew England Journal of Medicine, 1992
- TerbinafineDrugs, 1992
- Itraconazole therapy for nonmeningeal coccidioidomycosis: Clinical and laboratory observationsJournal of the American Academy of Dermatology, 1990